{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33914428",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "05",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "04",
        "Day": "28"
      }
    ],
    "Language": [
      "dut"
    ],
    "ELocationID": [
      "D6065"
    ],
    "Journal": {
      "ISSN": "1876-8784",
      "JournalIssue": {
        "Volume": "165",
        "PubDate": {
          "Year": "2021",
          "Month": "Apr",
          "Day": "28"
        }
      },
      "Title": "Nederlands tijdschrift voor geneeskunde",
      "ISOAbbreviation": "Ned Tijdschr Geneeskd"
    },
    "ArticleTitle": "[Temporary suspension of AstraZeneca's vaccine; a reconstruction].",
    "Abstract": {
      "AbstractText": [
        "In the middle of the worldwide COVID-19 crisis, the whole of Europe was alarmed about a possible side effect of the AstraZeneca vaccine against COVID-19. Consequently, the use of this AstraZeneca vaccine was temporarily suspended in many European nations including the Netherlands. In this article, we chronologically describe the decisions that were made about the use of this vaccine in the Netherlands and we discuss the risk-benefit ratios of these actions as well as possible non-medical reasons that may explain why these actions were taken."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Radboudumc, afd. Interne Geneeskunde, Nijmegen."
          },
          {
            "Identifier": [],
            "Affiliation": "Contact: D.P.M.S.M. Maas (dominique.maas@radboudumc.nl)."
          }
        ],
        "LastName": "Maas",
        "ForeName": "D P M S M",
        "Initials": "DPMSM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Radboudumc, afd. Interne Geneeskunde, Nijmegen(tevens: afd. Farmacologie-Toxicologie en Canisius Wilhelmina Ziekenhuis, afd. Klinische Farmacie, Nijmegen)."
          }
        ],
        "LastName": "Kramers",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Canisius Wilhelmina Ziekenhuis, afd. Klinische Farmacie, Nijmegen."
          }
        ],
        "LastName": "Smit",
        "ForeName": "H J C A",
        "Initials": "HJCA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Radboudumc, afd. Interne Geneeskunde, Nijmegen."
          }
        ],
        "LastName": "Middeldorp",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Radboud Universiteit, faculteit Bestuurskunde, Nijmegen."
          }
        ],
        "LastName": "Helsloot",
        "ForeName": "I",
        "Initials": "I"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ],
    "VernacularTitle": "Prikpauze AstraZeneca proportioneel?"
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Ned Tijdschr Geneeskd",
    "NlmUniqueID": "0400770",
    "ISSNLinking": "0028-2162"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Netherlands"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}